Recent Finacing
Recent Raise
InProTher is a Copenhagen biotech incubated at BioInnovation Institute developing HERV-targeting immunotherapies; lead candidate IPT001 uses adenoviral and RNA vectors, with preclinical activity in multiple solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at InProTher.
